Research / SYM / Fundamental state Inspectable configuration
State dimensions Filing 0001837240-24-000039 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.59% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-8.18% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
78.59% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
37.36% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
19.03% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-5.17% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
11.44% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
8.00% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Jun 25, 2022 0/4 normalized Level 3 Sep 24, 2022 0/7 normalized Level 3 Dec 24, 2022 0/7 normalized Level 3 Mar 25, 2023 0/7 normalized Level 3 Jun 24, 2023 0/8 normalized Level 3 Sep 30, 2023 0/8 normalized Level 3 Dec 30, 2023 0/8 normalized Level 3 Mar 30, 2024 0/8 normalized Level 3 Jun 29, 2024 4/8 normalized Level 3 Dec 30, 2023 0/8 normalized Amended as filed Mar 30, 2024 0/8 normalized Amended as filed Jun 29, 2024 4/8 normalized Amended as filed Sep 28, 2024 7/8 normalized Level 3 Dec 28, 2024 7/8 normalized Level 3 Mar 29, 2025 6/7 normalized Level 3 Jun 28, 2025 7/7 normalized Level 3 Sep 27, 2025 7/7 normalized Level 3 Dec 27, 2025 7/7 normalized Level 3 Mar 28, 2026 7/7 normalized Level 3 Jun 27, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 1.33%
Current 0.59%
Delta -0.74% Cash Generation Decreased
Previous 19.61%
Current -8.18%
Delta -27.79% Growth Decreased
Previous 98.36%
Current 78.59%
Delta -19.77% Inventory Pressure Increased
Previous 11.57%
Current 37.36%
Delta 25.80% Margin Increased
Previous 16.12%
Current 19.03%
Delta 2.91% Profitability Increased
Previous -18.97%
Current -5.17%
Delta 13.80% R And D Intensity Decreased
Previous 16.57%
Current 11.44%
Delta -5.13% Sbc Intensity Decreased
Previous 13.10%
Current 8.00%
Delta -5.11% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.